Stay updated on Xospata Safety in Relapsed AML Clinical Trial

Sign up to get notified when there's something new on the Xospata Safety in Relapsed AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Xospata Safety in Relapsed AML Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3 to the page history. Removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer/metadata.
    Difference
    0.1%
    Check dated 2025-12-23T08:10:16.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    A new revision v3.3.2 was added to the history and the previous revision v3.3.1 was removed from the list.
    Difference
    0.1%
    Check dated 2025-12-01T11:50:35.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Site-wide version update from v3.2.0 to v3.3.1; no changes to the study record content or history entries. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T11:27:37.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Removed the general funding/operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:14:47.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    Version 46 (2025-05-30) was added to the history with a Recruitment Status update for NCT04691648. The update documents changes to the study's recruitment status and related details.
    Difference
    0.1%
    Check dated 2025-11-03T00:46:20.000Z thumbnail image
  9. Check
    89 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    10%
    Check dated 2025-10-05T06:44:53.000Z thumbnail image

Stay in the know with updates to Xospata Safety in Relapsed AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Xospata Safety in Relapsed AML Clinical Trial page.